搜尋結果
The Oxford–AstraZeneca COVID-19 vaccine, sold under the brand names Vaxzevria [6] and Covishield, [7] is a viral vector vaccine [8] produced by the British University of Oxford, British-Swedish company AstraZeneca, and the Coalition for Epidemic Preparedness Innovations. [8] [9] [10] Finland, Denmark, and Norway suspended the use of the ...
GAVI, officially Gavi, the Vaccine Alliance[1] (previously the GAVI Alliance, and before that the Global Alliance for Vaccines and Immunization)[2] is a public–private global health partnership with the goal of increasing access to immunization in poor countries.[3] In 2016, Gavi channeled more than half of total donor assistance for health ...
e. The Oxford–AstraZeneca COVID‑19 vaccine, sold under the brand names Covishield [31] and Vaxzevria [1] [32] among others, is a viral vector vaccine for the prevention of COVID-19. It was developed in the United Kingdom by Oxford University and British-Swedish company AstraZeneca, [33] [34] [35] using as a vector the modified chimpanzee ...
according to International Monetary Fund estimates [n 1] [1] Countries by nominal GDP in 2019 [n 2] > $20 trillion. $10–20 trillion. $5–10 trillion. $1–5 trillion. $750 billion – $1 trillion. $500–750 billion. $250–500 billion.
For the Netherlands, based on overall excess mortality, an estimated 20,000 people died from COVID-19 in 2020, [9] while only the death of 11,525 identified COVID-19 cases was registered. [8] The official count of COVID-19 deaths as of December 2021 is slightly more than 5.4 million, according to World Health Organization's report in May 2022.
The COVID-19 pandemic, also known as the coronavirus pandemic, is a global pandemic of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The novel virus was first identified in an outbreak in Wuhan, the capital of Hubei, China, in December 2019, before it spread to other areas of Asia, and then worldwide in early 2020.
UNODC calculated a rate of 6.9 in 2010. [9] UNODC (United Nations Office on Drugs and Crime) reported a global average intentional homicide rate of 6.2 per 100,000 population for 2012 (in their report titled "Global Study on Homicide 2013"). [10] [11] In the 2019 edition, the global rate was estimated at 6.1 per 100,000 for 2017.
